NCT07636590ClinicalTrials.gov
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
باختصار
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
رصديةمطلوب 500 مشارك21 موقعاًدولة واحدة
الفئات
مسجَّلة في سجل واحد
- ClinicalTrials.govNCT07636590فتح هذا السجل في ClinicalTrials.govتمت المزامنة أول أمس
يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.
تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.
هل أنت مهتم بهذه الدراسة؟
تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 18 days after the recorded start)First posted 2026-06-09; recorded start 2026-05-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Claris Biotherapeutics, Inc.)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration3/5
Registered within 30 days of the study start
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 500 participants (target), run at 21 sites.
How this score is built
- Enrolment26/40
500 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 22 months
- Sponsor scale1/10
Claris Biotherapeutics, Inc. has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
ملخص
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
الحالات
- Limbal Stem Cell Deficiency
الأهلية
| الجنس | الجميع |
|---|---|
| الأعمار | 12 Years – 99 Years |
| المتطوعون الأصحّاء | لا |
| طريقة أخذ العينات | PROBABILITY_SAMPLE |
مجتمع الدراسة
Adult and adolescent subjects with qualifying LSCD
الأهلية كما كُتبت في السجل
الأهلية في عبارات بسيطة
لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.
تصميم الدراسة
| نوع الدراسة | رصدية |
|---|---|
| المرحلة | غير مذكور في سجل السجل |
| التخصيص | غير مذكور في سجل السجل |
| نموذج التدخّل | غير مذكور في سجل السجل |
| الغرض الأساسي | غير مذكور في سجل السجل |
| التعمية | غير مذكور في سجل السجل |
| التجنيد | مطلوب 500 مشارك |
الجهة الراعية والمتعاونون
- Claris Biotherapeutics, Inc. الجهة الراعية
الأذرع والتدخلات
- Non-interventional
No product administration.
التدخلات
- أخرى Non-interventional
Non-interventional
مقاييس النتائج
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes
Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires
الإطار الزمني Screening through Week 84
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Functional Changes (Photophobic BCVA)
Change in photophobic BCVA
الإطار الزمني Screening through Week 84
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Functional Changes (Low-luminance BCVA)
Change in low-luminance BCVA
الإطار الزمني Screening through Week 84
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Functional Changes (Low-contrast BCVA)
Change in low-contrast BCVA
الإطار الزمني Screening through Week 84
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Functional Changes (Contrast Sensitivity)
Change in contrast sensitivity (Pelli-Robson)
الإطار الزمني Screening through Week 84
مقياس النتيجة الأولي
Natural Progression of LSCD as Assessed by Anatomical/Structural Changes
Change in area of central cornea conjunctivalization
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Functional Changes (Corneal Sensitivity)
Changes (onset, improvement, or worsening) in corneal sensitivity
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Corneal Topography/Tomography)
Changes (onset, improvement, or worsening) in corneal topography and/or tomography and/or densitometry
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial Defect Frequency)
Changes (onset, improvement, or worsening) in epithelial defect frequency
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Palisades of Vogt Crypts)
Changes (onset, improvement, or worsening) in Palisades of Vogt crypts
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial and Total Corneal Thickness)
Changes (onset, improvement, or worsening) in epithelial and total corneal thickness
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Pannus)
Changes (onset, improvement, or worsening) in pannus
الإطار الزمني Screening through Week 84
مقياس النتيجة الثانوي
Changes that May be Correlated with LSCD as Assessed by Changes Ocular and Systemic Health Outcome Measures
Changes (onset, improvement/resolution, or worsening) of an existing condition
الإطار الزمني Screening through Week 84
التواريخ
| تاريخ البدء | 22 مايو 2026 (فعلي) |
|---|---|
| الإتمام الأولي | 1 مارس 2028 (تقديري) |
| الإتمام | 1 مارس 2028 (تقديري) |
| أول نشر | 9 يونيو 2026 (فعلي) |
| آخر تحديث | 18 نوفمبر 2026 |
| النتائج منشورة | غير مذكور في سجل السجل |
| آخر تأكيد للحالة | نوفمبر 2026 |
فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.
المواقع
21 موقعاً قيد التجنيد
United States
| المنشأة | المدينة | الولاية أو المنطقة | الحالة |
|---|---|---|---|
| Claris Investigative Site | Carmel | Indiana | قيد التجنيد |
| Claris Investigative Site | Cranberry Township | Pennsylvania | قيد التجنيد |
| Claris Investigative Site | Draper | Utah | قيد التجنيد |
| Claris Investigative Site | Huntington Beach | California | قيد التجنيد |
| Claris Investigative Site | Indianapolis | Indiana | قيد التجنيد |
| Claris Investigative Site | Kansas City | Missouri | قيد التجنيد |
| Claris Investigative Site | La Jolla | California | قيد التجنيد |
| Claris Investigative Site | Los Angeles | California | قيد التجنيد |
| Claris Investigative Site | Louisville | Kentucky | قيد التجنيد |
| Claris Investigative Site | Minnetonka | Minnesota | قيد التجنيد |
| Claris Investigative Site | Norfolk | Virginia | قيد التجنيد |
| Claris Investigative Site | Overland Park | Kansas | قيد التجنيد |
| Claris Investigative Site | Palisades Park | New Jersey | قيد التجنيد |
| Claris Investigative Site | Portland | Oregon | قيد التجنيد |
| Claris Investigative Site | Rockville Centre | New York | قيد التجنيد |
| Claris Investigative Site | San Antonio | Texas | قيد التجنيد |
| Claris Investigative Site | Sioux Falls | South Dakota | قيد التجنيد |
| Claris Investigative Site | Smyrna | Tennessee | قيد التجنيد |
| Claris Investigative Site | South Dartmouth | Massachusetts | قيد التجنيد |
| Claris Investigative Site | Tampa | Florida | قيد التجنيد |
| Claris Investigative Site | Wichita | Kansas | قيد التجنيد |
مستندات الدراسة
لا تُرتبط أي مستندات في سجل السجل هذا.
التغيّرات عبر الزمن
- 18 نوفمبر 2026
أُضيف موقع
13 sites added (21 total)
821
- 6 أغسطس 2026
أُضيف موقع
6 sites added (8 total)
28